KRYS Krystal Biotech Inc

$179.61

*Only the 1D chart reflects 15-min delayed quotes during market hours. Other timeframes update after market close.

Reporting for fiscal period ending —
Expected on —
Report Time: Unknown Release Time
The Whisper Number
—
Consensus Estimate: —
Revenue Estimate: —

Latest Earnings Insight

Updated On 10/2/2025

About Krystal Biotech Inc

Krystal Biotech, Inc., a clinical-stage biotechnology company, is dedicated to the field of redosable gene therapy to treat serious rare diseases in the United States. The company is headquartered in Pittsburgh, Pennsylvania.

Website: https://www.krystalbio.com

Sector
LIFE SCIENCES
Industry
BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)
Exchange
NASDAQ
Country
USA
Currency
USD
Fiscal Year End
December
CIK
1711279
Address
2100 WHARTON STREET, SUITE 701, PITTSBURGH, PA, US
Valuation
Market Cap
$4.87B
P/E Ratio
56.19
PEG Ratio
nan
Price to Book
5.15
Performance
EPS
$3.00
Dividend Yield
—
Profit Margin
30.70%
ROE
10.30%
Technicals
50D MA
$174.53
200D MA
$178.99
52W High
$219.34
52W Low
$141.72
Fundamentals
Shares Outstanding
29M
Target Price
$215.20
Beta
0.75

KRYS EPS Estimates vs Actual

● Estimated
● Actual

KRYS News & Sentiment

Sep 30, 2025 • Zacks Commentary SOMEWHAT-BULLISH
Krystal Biotech's Heavy Reliance on Vyjuvek: Growth Driver or Risk Factor?
KRYS gains momentum with Vyjuvek's expanded FDA label and global approvals, while advancing a pipeline led by oncology candidate KB707.
Sep 30, 2025 • Benzinga SOMEWHAT-BULLISH
6 Stocks Poised For Potential Acquisition In The Next 12 Months, According To Goldman Sachs, Including A 200% YTD Gainer - ( AACT ) , Walt Disney ( NYSE:DIS )
Goldman Sachs has highlighted six stocks that have a high probability of being acquisition targets in the next year. The bank reported that the total dollar value of M&A deals has risen 29% year-over-year, with deal volumes in 2025 climbing 8%. The bank projects an additional 15% increase in new ...
Sep 25, 2025 • Benzinga SOMEWHAT-BULLISH
If You Invested $1000 In Krystal Biotech Stock 5 Years Ago, You Would Have This Much Today - Krystal Biotech ( NASDAQ:KRYS )
Krystal Biotech ( NASDAQ: KRYS ) has outperformed the market over the past 5 years by 16.54% on an annualized basis producing an average annual return of 31.18%. Currently, Krystal Biotech has a market capitalization of $4.73 billion.
Sep 18, 2025 • Benzinga SOMEWHAT-BULLISH
Here's How Much $100 Invested In Krystal Biotech 5 Years Ago Would Be Worth Today - Krystal Biotech ( NASDAQ:KRYS )
Krystal Biotech KRYS has outperformed the market over the past 5 years by 15.05% on an annualized basis producing an average annual return of 29.98%. Currently, Krystal Biotech has a market capitalization of $4.64 billion.
Sep 17, 2025 • Zacks Commentary SOMEWHAT-BULLISH
Tango Therapeutics ( TNGX ) Soars 7.8%: Is Further Upside Left in the Stock?
Tango Therapeutics (TNGX) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate revisions for the stock suggests that there could be more strength down the road.
Sep 16, 2025 • Zacks Commentary SOMEWHAT-BULLISH
Krystal Biotech Stock Up on FDA Nod to Vyjuvek Label Update
KRYS shares jump after the FDA expands Vyjuvek's label to include DEB patients from birth, with added at-home use flexibility.
Sentiment Snapshot

Average Sentiment Score:

0.297
50 articles with scored sentiment

Overall Sentiment:

Bullish

KRYS Reported Earnings

May 05, 2025
Mar 31, 2025 (Pre market)
0.0 Surprise
  • Reported EPS: $0.00
  • Estimate: $1.03
  • Whisper: —
  • Surprise %: 0.0%
Feb 24, 2025
Dec 31, 2024 (Pre market)
-0.32 Surprise
  • Reported EPS: $1.53
  • Estimate: $1.85
  • Whisper: —
  • Surprise %: -17.4%
Nov 04, 2024
Sep 30, 2024 (Pre market)
0.01 Surprise
  • Reported EPS: $0.91
  • Estimate: $0.90
  • Whisper: —
  • Surprise %: 1.1%
Aug 05, 2024
Jun 30, 2024 (Pre market)
-0.05 Surprise
  • Reported EPS: $0.53
  • Estimate: $0.58
  • Whisper: —
  • Surprise %: -8.6%
May 06, 2024
Mar 31, 2024 (Pre market)
-0.12 Surprise
  • Reported EPS: $0.03
  • Estimate: $0.15
  • Whisper: —
  • Surprise %: -80.0%
Feb 26, 2024
Dec 31, 2023 (Pre market)
0.68 Surprise
  • Reported EPS: $0.30
  • Estimate: $-0.38
  • Whisper: —
  • Surprise %: 178.9%
Nov 06, 2023
Sep 30, 2023 (Pre market)
-0.4 Surprise
  • Reported EPS: $-0.69
  • Estimate: $-0.29
  • Whisper: —
  • Surprise %: -137.9%
Aug 07, 2023
Jun 30, 2023 (Pre market)
-0.51 Surprise
  • Reported EPS: $-1.25
  • Estimate: $-0.74
  • Whisper: —
  • Surprise %: -68.9%
May 08, 2023
Mar 31, 2023 (Pre market)
-0.32 Surprise
  • Reported EPS: $-1.76
  • Estimate: $-1.44
  • Whisper: —
  • Surprise %: -22.2%

Financials